Deutsche Bank Ag\ Forma Therapeutics Holdings, Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $6,707 - $19,066	-942 Reduced 5.85%	15,151 $302,000
Q2 2022 Aug 11, 2022	SELL	$5.1 - $10.0 $11,893 - $23,320	-2,332 Reduced 12.66%	16,093 $111,000
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $4.01 Million - $7.07 Million	-481,198 Reduced 96.31%	18,425 $171,000
Q4 2021 Feb 11, 2022	SELL	$13.6 - $24.89 $49,204 - $90,052	-3,618 Reduced 0.72%	499,623 $7.1 Million
Q3 2021 Nov 04, 2021	BUY	$21.22 - $25.7 $66,843 - $80,955	3,150 Added 0.63%	503,241 $11.7 Million

Q2 2021 Aug 11, 2021	BUY	$22.86 - $30.95 $22,768 - $30,826	996 Added 0.2%	500,091 $12.4 Million
Q1 2021 May 13, 2021	BUY	$24.58 - $42.82 $11.8 Million - $20.5 Million	478,200 Added 2288.59%	499,095 $14 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $428,572 - $627,262	12,280 Added 142.54%	20,895 $729,000
Q3 2020 Nov 12, 2020	BUY	$32.95 - $50.25 $283,864 - $432,903	8,615 New	8,615 $430,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.